Disease burden descriptions in trial protocols.

Autor: Tao BK; The University of British Columbia, Vancouver, BC, Canada., Xie JS; Department of Ophthalmology & Vision Science, Mount Sinai Hospital, University of Toronto, Toronto, ON M5T 3A9, Canada., Kohly RP; Department of Ophthalmology & Vision Science, Mount Sinai Hospital, University of Toronto, Toronto, ON M5T 3A9, Canada., Margolin E; Department of Ophthalmology & Vision Science, Mount Sinai Hospital, University of Toronto, Toronto, ON M5T 3A9, Canada. Electronic address: emargolin@mtsinai.on.ca.
Jazyk: angličtina
Zdroj: Lancet (London, England) [Lancet] 2024 Jul 20; Vol. 404 (10449), pp. 238-239.
DOI: 10.1016/S0140-6736(24)00881-X
Databáze: MEDLINE